Paul V. Maier
Director · International Stem Cell CORP
IndividualSelling only
- 2025
- Sep 18, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul V. Maier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Brynjelsen - $9.91M in ETON purchases and sales in the last 12 months
- Opaleye Management Inc. - $6.89M in ETON purchases and sales in the last 12 months
- David Krempa - $5.09M in ETON purchases and sales in the last 12 months
- Jennifer McKie Adams - $1.62M in ETON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul V. Maier?
Paul V. Maier is a corporate insider, tracked as Director of International Stem Cell CORP (ISCO). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul V. Maier submitted recently?
5 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Paul V. Maier been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($5.92M) across all tracked filings.
